Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lucosky Brookman LLP takes Akers Biosciences, Inc. Public on NASDAQ


Thursday, 3 Apr 2014 10:00am EDT 

Lucosky Brookman LLP:Client Akers Biosciences, Inc has successfully completed initial public offering of common stock and commenced trading on NASDAQ Capital Markets.Lucosky Brookman will join Akers Biosciences to ring closing bell on floor of NASDAQ on July 9. 

Company Quote

3.485
0.215 +6.57%
26 Dec 2014